CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Dec. 27, 2013		Dec. 28, 2012
Cash flows from operating activities:
Net earnings	$ 97,960		$ 95,283
Adjustments to reconcile net earnings to net cash provided by operating activities:
Share-based compensation expense	9,044		10,163
Tax benefits from exercises of share-based payment awards	3,879		5,321
Excess tax benefits from share-based compensation	(3,877)		(4,937)
Depreciation	15,013		15,840
Amortization of intangible assets	1,052		1,116
Deferred taxes	6,600		4,150
Provision for doubtful accounts receivable	(229)		3,769
Income on equity investment in affiliate	1,391		(179)
Other, net	(291)		(1,108)
Changes in assets and liabilities, net of effect of acquisition:
Accounts receivable	(19,295)		53,119
Inventories	(24,348)		(41,015)
Prepaid expenses and other assets	(226)		(14,627)
Accounts payable	(10,744)		(33,358)
Accrued expenses and other liabilities	(24,806)		(39,113)
Deferred revenues and advance payments from customers	(7,862)		17,457
Net cash provided by operating activities	43,261		71,881
Cash flows from investing activities:
Purchases of property, plant and equipment	(24,482)		(20,004)
Investment in corporate debt security	(9,876)		(1,384)
Net amounts paid to deferred compensation plan trust account	0		(2,120)
Other	(1,407)		(465)
Net cash used in investing activities	(35,765)		(23,973)
Cash flows from financing activities:
Repurchases of common stock	(155,503)		(103,551)
Proceeds from issuance of common stock to employees	30,556		58,929
Excess tax benefits from share-based compensation	3,877		4,937
Employees’ taxes withheld and paid for restricted stock and restricted stock units	(8,302)		(4,402)
Net borrowings under line of credit agreements	0		45,000
Repayments under term loan facility	(25,000)		0
Other	(204)		(25)
Net cash provided/(used) in financing activities	(154,576)		888
Effects of exchange rate changes on cash and cash equivalents	412		2,123
Net increase/(decrease) in cash and cash equivalents	(146,668)		50,919
Cash and cash equivalents at beginning of period	1,117,861	[1]	704,570
Cash and cash equivalents at end of period	$ 971,193		$ 755,489

[1] The condensed consolidated balance sheet as of September 27, 2013 was derived from audited financial statements as of that date, but does not include all disclosures required by accounting principles generally accepted in the United States of America.